Show simple item record

dc.contributor.authorPayne, A
dc.contributor.authorChristodoulou, Marianna
dc.contributor.authorKhalil, N
dc.contributor.authorRust, P
dc.contributor.authorThompson, David J
dc.contributor.authorSmith, Ed
dc.contributor.authorHowell, Sacha J
dc.contributor.authorFenemore, Jackie
dc.contributor.authorNeal, Hilary
dc.contributor.authorBarker-Hewitt, Matthew
dc.contributor.authorSykes, S
dc.contributor.authorDale, W
dc.contributor.authorBristow, Robert G
dc.contributor.authorPrice, J
dc.contributor.authorYorke, Janelle
dc.contributor.authorFaivre-Finn, Corinne
dc.date.accessioned2021-01-06T11:15:16Z
dc.date.available2021-01-06T11:15:16Z
dc.date.issued2020en
dc.identifier.citationPayne A, Christodoulou M, Khalil N, Rust P, Thompson DJ, Smith E, et al. Implementing electronic patient reported outcome measures (ePROMs) into routine lung cancer follow- up: the patient perspective. Lung Cancer. 2020;139:S86-S7en
dc.identifier.urihttp://hdl.handle.net/10541/623578
dc.description.abstractIntroduction: PROMs have been shown to improve survival and quality of life in oncology patients within the scope of clinical trials. Our organisation is the first UK institution to implement large scale electronic PROMs (ePROMs) collection into routine lung cancer care. This study investigates patient experiences of using ePROMs. Methods: Lung cancer patients who had completed (either alone or with help from a proxy) ≥1 ePROMs questionnaire were approached to complete a Patient Reported Experience Measure (PREM) survey analysing their experiences. Results: Between May and June 2019 107 lung and head-and-neck cancer patients were approached to complete a PREM. Of the total 100 completed PREMs, 78 patients had lung cancer. Median age 68.5 years; 54% female. Most patients had a performance status ≤1 (84%), stage III/IV disease (78%) and an Adult Comorbidity Evaluation Score of 0–1 (73%). All patients found ePROMs easy to understand and most (98%) found it easy to follow and timely to complete. Sixty-two (79%) patients reported improved communication with their clinical team and 69 (89%) patients felt more involved in their care. Eighty-five percent (23/27) of patients who reported seeking medical advice, felt that ePROMs prompted them do so sooner. Some patients commented that clinicians were not discussing their ePROMs results during their appointment. Compliance data for lung and head-and-neck patients was collected from January 2019 until June 2019. Overall compliance rate was 35%. Conclusion: Routine use of ePROMs in lung cancer is feasible and acceptable to patients. Further work is needed to improve patient and clinician compliance, explore the experiences of non-compliant patients and investigate the impact of the ePROMs service on other hospital services.en
dc.language.isoenen
dc.titleImplementing electronic patient reported outcome measures (ePROMs) into routine lung cancer follow- up: the patient perspectiveen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchesteren
dc.identifier.journalLung Canceren
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record